When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs

When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs
With a flagship treatment that helps fewer than 11,000 people, how is Alexion making so much money?

May 25, 2017 at 06:20PM
via Digg http://ift.tt/2qXFqDJ